Europe PMC
open access
Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical innovations and future directions of nanoparticles in the treatment of psychiatric and neurological disorders#431858
- Nanomedicine for Depression: From Blood-Brain Barrier Delivery to Neuroimmune-Barrier-Plasticity Network Reprogramming.#345176
- Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528
- Plant-mediated green nanoparticles: combining nanometal and biometabolite potential for Alzheimer's treatment.#472372
- Screening For Potential Compounds Using Drug-Repurposing And Virtual Screening Of N-Methyl-S-Aspartate (Nmda) Receptor For Autism Spectrum Disorder (Asd)#190850
Record · ID 651743
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive